Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Amortization of Debt Discount (Premium)

1.5 / 5 stars · 27/93 Roast Me

VYOME HOLDINGS, INC. Amortization of Debt Discount (Premium)

VYOME HOLDINGS, INC. (HIND) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.

Discontinued › Cash Flow › Operating Activities

us-gaap:AmortizationOfDebtDiscountPremium · last filed 2021-03-12

  • VYOME HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2020-12-31 was $0.00.
  • VYOME HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2020-09-30 was $0.00.
  • VYOME HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
  • VYOME HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
  • VYOME HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
  • VYOME HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2019 was $70.00K, a 89.19% increase from fiscal 2018.
  • VYOME HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2018 was $37.00K, a 11.90% decline from fiscal 2017.
  • VYOME HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2017 was $42.00K, a 40.00% decline from fiscal 2016.
Period endAmortization of Debt Discount (Premium) 3 monthAmortization of Debt Discount (Premium) 6 monthAmortization of Debt Discount (Premium) 9 monthAmortization of Debt Discount (Premium) 12 month
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$0.00
derived: sum of 2 quarters · filed 2021-03-12
$0.00
derived: sum of 3 quarters · filed 2021-03-12
$0.00
10-K · filed 2021-03-12
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$0.00
derived: sum of 2 quarters · filed 2020-11-06
$0.00
10-Q · filed 2020-11-06
$0.00
derived: sum of 4 quarters · filed 2021-03-12
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$0.00
10-Q · filed 2020-07-30
$0.00
derived: sum of 3 quarters · filed 2021-03-12
$0.00
derived: sum of 4 quarters · filed 2021-03-12
2020-03-31$0.00
10-Q · filed 2020-06-19
$0.00
derived: sum of 2 quarters · filed 2021-03-12
$0.00
derived: sum of 3 quarters · filed 2021-03-12
$48.00K
derived: sum of 4 quarters · filed 2021-03-12
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$0.00
derived: sum of 2 quarters · filed 2021-03-12
$48.00K
derived: sum of 3 quarters · filed 2021-03-12
$70.00K
10-K · filed 2021-03-12
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$48.00K
derived: sum of 2 quarters · filed 2020-11-06
$70.00K
10-Q · filed 2020-11-06
$78.00K
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$48.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$70.00K
10-Q · filed 2020-07-30
$78.00K
derived: sum of 3 quarters · filed 2020-07-30
$85.00K
derived: sum of 4 quarters · filed 2020-07-30
2019-03-31$22.00K
10-Q · filed 2020-06-19
$30.00K
derived: sum of 2 quarters · filed 2020-06-19
$37.00K
derived: sum of 3 quarters · filed 2020-06-19
$48.00K
derived: sum of 4 quarters · filed 2020-06-19
2018-12-31$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$15.00K
derived: sum of 2 quarters · filed 2020-02-27
$26.00K
derived: sum of 3 quarters · filed 2020-02-27
$37.00K
10-K · filed 2020-02-27
2018-09-30$7.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$18.00K
derived: sum of 2 quarters · filed 2019-11-08
$29.00K
10-Q · filed 2019-11-08
$40.00K
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30$11.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
$22.00K
10-Q · filed 2019-07-24
$33.00K
derived: sum of 3 quarters · filed 2019-07-24
$44.00K
derived: sum of 4 quarters · filed 2019-07-24
2018-03-31$11.00K
10-Q · filed 2019-05-10
$22.00K
derived: sum of 2 quarters · filed 2019-05-10
$33.00K
derived: sum of 3 quarters · filed 2019-05-10
$43.00K
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$11.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$22.00K
derived: sum of 2 quarters · filed 2019-02-22
$32.00K
derived: sum of 3 quarters · filed 2019-02-22
$42.00K
10-K · filed 2019-02-22
2017-09-30$11.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$21.00K
derived: sum of 2 quarters · filed 2018-11-02
$31.00K
10-Q · filed 2018-11-02
$41.00K
derived: sum of 4 quarters · filed 2018-11-02
2017-06-30$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$20.00K
10-Q · filed 2018-08-02
$30.00K
derived: sum of 3 quarters · filed 2018-08-02
$47.00K
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$10.00K
10-Q · filed 2018-05-10
$20.00K
derived: sum of 2 quarters · filed 2018-05-10
$37.00K
derived: sum of 3 quarters · filed 2018-05-10
$59.00K
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$27.00K
derived: sum of 2 quarters · filed 2018-03-05
$49.00K
derived: sum of 3 quarters · filed 2018-03-05
$70.00K
10-K · filed 2018-03-05
2016-09-30$17.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$39.00K
derived: sum of 2 quarters · filed 2017-11-03
$60.00K
10-Q · filed 2017-11-03
$82.00K
derived: sum of 4 quarters · filed 2018-03-05
2016-06-30$22.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$43.00K
10-Q · filed 2017-08-02
$65.00K
derived: sum of 3 quarters · filed 2018-03-05
2016-03-31$21.00K
10-Q · filed 2017-05-10
$43.00K
derived: sum of 2 quarters · filed 2018-03-05
2015-12-31$22.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$79.00K
10-K · filed 2018-03-05
2015-09-30$57.00K
10-Q · filed 2016-11-10
2014-12-31$41.00K
10-K · filed 2017-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36